Clinical Trial: Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access:   Available for Individual Patients

Official Title: Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Brief Summary: A subject was treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rather than the Max Sep (Baxter) device.

Detailed Summary:
Sponsor: University of Louisville

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Louisville

Dates:
Date Received: March 7, 2014
Date Started:
Date Completion:
Last Updated: March 17, 2017
Last Verified: March 2017